OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Kelly Lauds Trump Administration for Lowering Cost of Insulin for America's Seniors

Statement

Date: May 26, 2020
Location: Washington, DC
Issues: Senior Citizens Health and Health Care

Washington, D.C. - Today, the U.S. Centers for Medicare and Medicaid Services (CMS) unveiled plans to lower the cost of insulin and expand coverage for diabetes treatments for seniors with Medicare Part D and Medicare Advantage drug plans. U.S. Representative Mike Kelly (R-Pa.), a member of the Congressional Diabetes Caucus and a diabetic himself, issued this statement after the announcement:

"The sky-rocketing price of insulin has caused great hardship for millions of Americans with diabetes. I applaud President Trump for fighting to lower seniors' out-of-pocket costs and look forward to working with him to make this life-saving drug affordable for all Americans who depend on it."


Source
arrow_upward